Pharmaceutical and Biotech Facility Construction Across Ontario
These facilities are designed for the large-scale production of pharmaceutical products, encompassing synthesis, formulation, and packaging. Construction prioritizes robust infrastructure for process automation, material handling, and adherence to strict GMP cleanliness protocols.
We build advanced research and development laboratories for biological products, often featuring specialized cleanrooms, vivariums, and dedicated instrumentation suites. These spaces are engineered for flexibility to accommodate evolving scientific experiments and diverse analytical platforms.
Our expertise extends to highly specialized facilities for developing and producing living cell and gene-based treatments, demanding ultra-sterile environments and stringent contamination control. These projects require meticulous attention to aseptic processing zones and segregated workflows.
Construction for Active Pharmaceutical Ingredient (API) production involves facilities for complex chemical synthesis and purification processes. These builds focus on robust containment strategies, explosion-proof environments, and specialized material transfer systems to ensure product integrity and safety.
We deliver controlled environments specifically for the production, assembly, and packaging of medical instruments and devices. These facilities are built to meet ISO 13485 quality management standards, featuring precise environmental control and contamination prevention measures.
These projects involve the construction of aseptic processing and packaging suites for injectable drugs and biologics. Critical cleanroom technology, validated HVAC systems, and automated filling lines are central to ensuring the sterility and safety of final drug products.
We build analytical and microbiological testing laboratories essential for ensuring product safety, efficacy, and batch consistency. These facilities are equipped with precision instrumentation, dedicated sample handling areas, and robust data integrity systems to support regulatory compliance.
Our pilot plant construction focuses on smaller-scale facilities designed for process development, optimization, and early-stage production of novel compounds or therapies. These environments are engineered for maximum flexibility, rapid reconfigurability, and scalability to accelerate product development cycles.
Design and construction of ISO classified cleanrooms (ISO 5-8), aseptic suites, and biosafety laboratories (BSL-1 to BSL-3) with integrated environmental monitoring systems for precise particulate and microbial control.
Installation of high-efficiency HEPA filtration systems, precise temperature and humidity control, purified water generation and distribution systems (PW/WFI), and specialized process gas piping for critical operations.
Seamless integration and commissioning of complex manufacturing equipment such as bioreactors, fermenters, chromatography systems, lyophilizers, and automated production lines within cleanroom environments.
Implementation of features crucial for GMP/GLP adherence, including segregated material and personnel flow, robust access control systems, validated data integrity infrastructure, and detailed documentation protocols.
Custom design and installation of laboratory casework, fume hoods, biosafety cabinets, vibration isolation tables, and specialized lab furniture tailored for specific research, development, and quality control functions.
Engineering and installation of advanced ventilation, exhaust scrubbers, spill containment, emergency showers and eye wash stations, and hazardous material storage solutions to ensure personnel and product safety.
| Project Subtype | Size Range | Low (per sq ft) | Mid (per sq ft) | Premium (per sq ft) |
|---|---|---|---|---|
| Drug Manufacturing | 50,000 - 300,000+ sq ft | $450 | $700 | $1,000+ |
| Biotech Research | 20,000 - 100,000 sq ft | $400 | $650 | $900+ |
| Cell & Gene Therapy | 10,000 - 50,000 sq ft | $600 | $850 | $1,200+ |
| API Production | 30,000 - 150,000 sq ft | $500 | $750 | $1,100+ |
| Medical Device Manufacturing | 15,000 - 80,000 sq ft | $350 | $550 | $800+ |
| Sterile Fill-Finish | 5,000 - 40,000 sq ft | $700 | $950 | $1,300+ |
| Quality Control Lab | 5,000 - 25,000 sq ft | $300 | $500 | $750+ |
| Pilot Plant | 10,000 - 30,000 sq ft | $480 | $720 | $1,050+ |
This phase involves detailed feasibility studies, site selection, comprehensive regulatory review, and advanced engineering design for specialized life sciences infrastructure. Procurement strategies for long-lead equipment are also finalized.
Work includes site grading, utility rough-ins, and the construction of robust foundation systems specifically designed to support heavy process equipment and mitigate vibrations for sensitive laboratory instruments.
This phase focuses on erecting the building envelope, structural framing, and installing critical infrastructure like specialized utility mains, HVAC risers, and initial fire suppression systems tailored for life sciences facilities.
Cleanroom construction, installation of controlled environments, complex process piping, advanced electrical systems, laboratory casework, and specialized finishes critical for aseptic and research operations are completed.
Rigorous testing, validation (IQ/OQ/PQ), comprehensive regulatory inspections, and thorough training for facility operators ensure all systems perform as intended and the facility is fully compliant and ready for GMP operations.
Good Manufacturing Practice (GMP) facilities regulated by Health Canada under Division 2 of the Food and Drug Regulations require: validated HVAC systems with pressure cascades (typically +12.5 Pa between clean and less-clean zones), HEPA filtration on supply air, 100% exhaust in potent compound areas, smooth coved finishes on all surfaces, epoxy or polished concrete flooring, and extensive process instrumentation and data logging. GMP qualification (IQ/OQ/PQ) of all critical systems adds 15-25% to project costs.
Research labs are designed for scientific flexibility — movable casework, plentiful utilities at every bench, and reconfigurable spaces. GMP manufacturing facilities are designed for validated, reproducible processes — fixed equipment, defined material flow paths (unidirectional clean to dirty), personnel airlocks, and strict separation of raw material, manufacturing, and finished goods zones. GMP facilities cost 2-4x more per square foot than equivalent research labs due to these requirements.
A new pharmaceutical manufacturing facility in Ontario typically takes 24-48 months from design start to first batch release: 6-12 months for design and permits, 18-36 months for construction and commissioning, 6-12 months for Health Canada Drug Establishment Licence (DEL) application review. Experienced contractors who understand GMP construction sequencing and commissioning requirements can significantly reduce the validation and licensing timeline.